Dr. Kai from Safety BU to Deliver an Oral Presentation at the 9th Drug Discovery & Lead Optimization Conference
Dr. Kiyonori Kai from the Safety Business Unit, will deliver an oral presentation at The 9th Drug...
Researcher Tanaka and Ogawa from Pharmacology BU to Present at a symposium hosted by CIEM
Our researcher, Hiroshi Tanaka and Masahiro Ogawa from the Pharmacology Business Unit, will give an oral presentation...
Researcher Tabata from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association
Our researcher, Ryotaro Tabata from the Pharmacology Business Unit, will present a poster at the 84th Annual...
Researcher Unno from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association
Our researcher, Satoko Unno from the Pharmacology Business Unit, will present a poster at the 84th Annual...
PRD Therapeutics Initiates First-in-Human Clinical Trial of SOAT2-Selective Inhibitor ‘PRD001’ — Axcelead DDP Provides Comprehensive Non-Clinical Development Support —
PRD Therapeutics, Inc. (“PRD Therapeutics”), a clinical stage company focused on developing novel lipid metabolism regulators targeting homozygous...
Researcher Oki from Screening BU to Deliver an Oral Presentation at the 52nd Annual Workshop of the Japanese Society of Toxicology
Our researcher, Hideyuki Oki from the Screening Business Unit, will deliver an oral presentation at the 52nd...